动脉粥样硬化性肾动脉狭窄支架治疗_第1页
动脉粥样硬化性肾动脉狭窄支架治疗_第2页
动脉粥样硬化性肾动脉狭窄支架治疗_第3页
动脉粥样硬化性肾动脉狭窄支架治疗_第4页
动脉粥样硬化性肾动脉狭窄支架治疗_第5页
已阅读5页,还剩18页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Unilateral atherosclerotic renal artery stenosis: the change of total and separate kidney function following stenting1Patient: A 70-year-old man with a 15-year history of hypertension, left renal artery stenosis (RAS) due to atherosclerosis and stenosis judged to be above 70% by doppler ultrasonogra

2、phy . RI=0.65 Systolic BP: 175mmHg; dastolic BP: 98 mmHg. biochemical tests indicated: creatinine : 2.55 mg/dl Cr. Clearance: 45.3ml/min2Question:l Whether he can undergo stentiong? YESl Can stenting of RAS due to atherosclerosis be followed by stabilization or improvement of Ccr at the stented kidn

3、ey? YES lHow will this effect the renal funcion of the contralateral renal ? UNKNOWN 3Retrieve:lKey words : atherosclerotic renal artery stenosis stenting kidney functionlRetrieval limits : Clinical Trial Meta-Analysis Randomized Controlled TriallDatabase: Clinical evidence; Cochrane Library; Pubmed

4、; and so on 4Search outcome:Pubmed:lBMC Nephrology 2004, 5:15 doi:10.1186/1471-2369-5-15l Atherosclerotic renal artery stenosis: one year outcome of total and separate kidney function following stentingBMA:英国医学师协会5Evaluation:l validity(真实实性)l importance(重要性)l application(适用性)6 Validity:lWas the assi

5、gnment of patients to treatment randomized? RCTlWere the groups similar at the start of the trial? Clinical and biochemical data of the treated and control groups are reported in Table 1. There was no significant difference between experimental and control groups78 Validity: Methods The group of 27

6、patients, 67.33 6.8 years of age, creatinine of 2.15 0.9 mg/dl, following stenting, were followed at intervals with biochemical tests, renal scintigraphy and doppler ultrasonography. The control group of 19 patients (70.0 6.1 years, creatinine 1.99 0.7 mg/dl) was also followed for one year. All pati

7、ents had a unilateral stenosis judged by ultrasonography to be above 70%.9 Validity:lWas follow-up of patients sufficiently long and complete? During 12 months observation period one patient of the stented group began dialysis treatment, while in the control group 4 patients died of cardiovascular e

8、vents and one patient started the dialysis treatment.lWere all patients analyzed in the groups to which they were? efficacy analysis10Validity:lWere patients, clinicians, and study personnel kept blind to treatment? a double-blind controlled triallWere groups treated equally, apart from the experime

9、ntal therapy? No other therapies.11Evaluation:l validityl importancel application12ImportancelHow precise is this estimate of the treatment effect? 95%CIlWhat is the magnitude of the treatment effect?13A significant drop in systolic and diastolic blood pressure at all control times compared to basal

10、 values, was found in the stented patients.While no significant blood pressure drop was found in the patients not undergoing the PTA stenting procedure 14 An increase in creatinine clearance and a slight fall in serum creatinine, however not reaching a significance level, was observed in the stented

11、 group.While no increment in creatinine clearance was found in the control group.15An increment in the percentage of total glomerular filtration in the stented kidney as a group was found.While a significant fall in percentage of filtration was found on the controlateral side.The overall renal funct

12、ion was stable.16Evaluation:l validityl importantl application17lIs our patient so different from those in the study that its result cannot apply? 70 years of age left renal artery stenosis (RAS) due to atherosclerosis stenosis judged to be above 70% RI=0.65lIs the treatment feasible in our setting?

13、 Implementation technique level Monitoring and management level Economic burden Patients will Application18ApplicationlWhat are our patients values and expectations for both the outcome we are trying to prevent and the treatment we are offering? Stenting of RAS due to atherosclerosis is followed by

14、stabilization or improvement of Ccr, mainly at the stented kidney, while contralateral renal function showed a decrease. The reduction in contralateral kidney function has been attributed to ultrafiltration in the non stenotic kidney, declining after stenting of the stenotic contralateral renal arte

15、ry. In addition, hemodynamic factors consequent to a decrease in renin-angiotensin activity could be considered as a factor.19Resistance index appeared to be a risk factor of the functional outcome.2021ApplicationTherefore, also in case of overall stabilization of renal function following the stenting procedure, improvement of the stented side and reduction of hyperfiltration on the contralateral side are both favorable evolutions for long-

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论